MarkAngelAgiusMD

PubMed

• 49 citations
  Safety and efficacy of MD1003 (high-dose biotin) in patients with progressive multiple sclerosis (SPI2): a randomised, double-blind, placebo-controlled, phase 3 trial.
  Bruce A.C. Cree, Gary Cutter, Jerry S. Wolinsky, M. S. Freedman, Giancarlo Comi, Gavin Giovannoni, Hans-Peter Hartung, Douglas L. Arnold, Jens Kuhle, Valerie J Block, ...> ;The Lancet. Neurology. 2020 Dec 1
• 34 citations
  Immune thrombocytopenia in alemtuzumab-treated MS patients: Incidence, detection, and management.
  Adam Cuker, Ann D Bass, Congor Nadj, Mark A Agius, Brian Steingo, Krzysztof Selmaj, Timothy Thoits, Alexandre Guerreiro, Bart Van Wijmeersch, Tjalf Ziemssen, Sven G. M...> ;Multiple Sclerosis. 2020 Jan 1
• 92 citations
  Safety and tolerability of inebilizumab (MEDI-551), an anti-CD19 monoclonal antibody, in patients with relapsing forms of multiple sclerosis: Results from a phase 1 ra...
  Mark Agius, Gabriela Klodowska-Duda, Maciej Maciejowski, Andrzej Potemkowski, Jing Li, Kaushik Patra, Jacob Wesley, Soraya Madani, Gerard Barron, Eliezer Katz, Armando...> ;Multiple Sclerosis. 2019 Feb 1
• 51 citations
  Design, rationale, and baseline characteristics of the randomized double-blind phase II clinical trial of ibudilast in progressive multiple sclerosis
  Robert J. Fox, Christopher S. Coffey, Merit Cudkowicz, Trevis Gleason, Andrew D. Goodman, Eric C. Klawiter, Kazuko Matsuda, Michelle McGovern, Robin Conwit, Robert T. ...> ;Contemporary Clinical Trials. 2016 Sep 1
• 1 citations
  STIGMA IN MALTA; A MEDITERRANEAN PERSPECTIVE
  Mark Agius, Francesca Falzon Aquilina, Charles Pace, Anton Grech> ;Psychiatria Danubina. 2016 Aug 30
• 19 citations
  Impact of a switch to fingolimod on depressive symptoms in patients with relapsing multiple sclerosis: An analysis from the EPOC (Evaluate Patient OutComes) trial.
  Samuel F. Hunter, Mark Agius, Deborah M. Miller, Gary Cutter, Luigi Barbato, Kevin McCague, Xiangyi Meng, Neetu Agashivala, Peter Chin, Eric Hollander> ;Journal of the Neurological Sciences. 2016 Jun 15
• SHOULD MEASUREMENT OF COGNITION BE PART OF RECOVERY PROGRAMS FOR PATIENTS WITH PSYCHOTIC ILLNESS
  Mark Agius, Yuliya Zaytseva> ;Psychiatria Danubina. 2015 Sep 8
• 1 citations
  The Cambridge-Perugia Inventory for assessment of Bipolar Disorder.
  Mark Agius, Norma Verdolini> ;Psychiatria Danubina. 2015 Sep 8
• Could Carmelite Spirituality Promote Good Mental Health? A brief Tribute to Saint Teresa of Avila in the 500th anniversary of her birth.
  Mark Agius> ;Psychiatria Danubina. 2015 Sep 8
• 1 citations
  Co-Morbidity Part 2 - Neurobiology and Suicide Risk; Modelling the consequences of Bipolar and Anxiety Co-Morbidity.
  Mark Agius, Norma Verdolini, Francesca Falzon Aquilina, Sophie Butler> ;Psychiatria Danubina. 2014 Nov 1
• 1 citations
  Can metabolic side effects of antipsychotics be reversed by lifestyle changes
  Alistair Bolger, Norma Verdolini, Mark Agius> ;Psychiatria Danubina. 2014 Nov 1
• 10 citations
  Atypical Anti-Psychotics in Adult Bipolar Disorder: Current Evidence and Updates in the NICE guidelines.
  Stephanie Xiu Wern Poo, Mark Agius> ;Psychiatria Danubina. 2014 Nov 1
• 1 citations
  Combining antipsychotics; is this strategy useful?
  Jill Christy, David Burnside, Mark Agius> ;Psychiatria Danubina. 2014 Nov 1
• BIPOLAR DISORDER: THE IMPORTANCE OF CLINICAL ASSESSMENT IN IDENTIFYING PROGNOSTIC FACTORS - AN AUDIT. Part 3: A comparison between Italian and English mental health se...
  Norma Verdolini, Jonathon Dean, G. P. Massucci, Sandro Elisei, Roberto Quartesan, Rashid Zaman, Mark Agius> ;Psychiatria Danubina. 2014 Nov 1
• 7 citations
  Bipolar disorder: The importance of clinical assessment in identifying prognostic factors - An Audit. Part 2: Mixed state features and rapid cycling.
  Norma Verdolini, Jonathon Dean, Sandro Elisei, Roberto Quartesan, Rashid Zaman, Mark Agius> ;Psychiatria Danubina. 2014 Nov 1
• 5 citations
  Bipolar disorder: The importance of clinical assessment in identifying prognostic factors - An Audit. Part 1: An analysis of potential prognostic factors.
  Norma Verdolini, Jonathon Dean, Sandro Elisei, Roberto Quartesan, Rashid Zaman, Mark Agius> ;Psychiatria Danubina. 2014 Nov 1
• 9 citations
  Do atypical antipsychotics improve cognition
  Yasmin Walters, Mark Agius> ;Psychiatria Danubina. 2014 Nov 1
• 15 citations
  A review of the adverse side effects associated with antipsychotics as related to their efficacy.
  Jina Pakpoor, Mark Agius> ;Psychiatria Danubina. 2014 Nov 1
• 3 citations
  Anti-NMDA Encephalitis in the Acute Setting.
  John E. Lawrence, Daniel M Fountain, Mark Agius> ;Psychiatria Danubina. 2014 Nov 1
• The multifactorial etiology of eating disorders outlined in a case of anorexia nervosa and complicated by psychiatric co-morbidities.
  Francesca Falzon Aquilina, Mark Agius, Kriti Sharma> ;Psychiatria Danubina. 2014 Nov 1
• 1 citations
  Comorbidities and psychotic illness. Part 1: Philosophy and clinical consequences.
  Mark Agius, Francesca Falzon Aquilina> ;Psychiatria Danubina. 2014 Nov 1
• An Audit Of Obsessive Compulsive Disorder in A Bedford (UK) Community Mental Health Team.
  Kenwoo Yi, James Austin, Mark Agius, Rashid Zaman> ;Psychiatria Danubina. 2014 Nov 1
• 3 citations
  The impact of guidance on citalopram's effects on the QT period on the practice of clinicians.
  James Austin, Keonwoo Yi, Mark Agius, Rashid Zaman> ;Psychiatria Danubina. 2014 Nov 1
• THE MULTIDISCIPLINARY APPROACH TO MOOD DISORDERS
  Francesca Falzon Aquilina, Mark Agius, Kriti Sharma, Anton Grech> ;Psychiatria Danubina. 2014 Nov 1
• 1 citations
  Petals: An Assessment of the Outcomes of a Service for Bereavement during Childbirth.
  Molly Spink, Abi Magrill, Karen Burgess, Jonathan Rogers, Mark Agius> ;Psychiatria Danubina. 2014 Nov 1
• Join now to see all